Aldeyra Therapeutics, Inc.

US$0.63As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALDXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (19.02%)
Div yield —
ROE (45.29%)
Biotechnology
Beta (5Y) 1.29
PE TTM —
TSR TTM (87.50%)
Mkt cap US$38.23M
ROIC (25.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.726
14.60%
(30.29%)
Hold 12|5|2|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
17.87%
20.67%
29.71%
19.76%
Revenue$M
4.048
4.091
3.984
3.947
9.80%
6.03%
3.15%
(3.26%)
Peers (US$38.23M)
Cap (US$)
PE
38.31M
—
Capital
TTM
5Y
10Y
Leveragex
1.995
0.239
0.263
EBIT/Intx
3.668
0.125
0.132
Own earn%
(45.81)
9.10
(4.69)
Sh yield%
38.29
41.31
38.98
Owners
Insiders/Inst%
4.79
41.90
Short interest%
5.77
SBC / revenue%
3.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
22–26
$1 testx
—
Incr. ROIC%
9